GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » EV-to-FCF

Kimia Biosciences (BOM:530313) EV-to-FCF : (As of Jun. 05, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Kimia Biosciences's Enterprise Value is ₹2,302.71 Mil. Kimia Biosciences does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Kimia Biosciences's EV-to-FCF at this moment.

The historical rank and industry rank for Kimia Biosciences's EV-to-FCF or its related term are showing as below:

BOM:530313's EV-to-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.76
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), Kimia Biosciences's stock price is ₹48.67. Kimia Biosciences does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Kimia Biosciences's PE Ratio at this moment.


Kimia Biosciences EV-to-FCF Historical Data

The historical data trend for Kimia Biosciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences EV-to-FCF Chart

Kimia Biosciences Annual Data
Trend
EV-to-FCF

Kimia Biosciences Semi-Annual Data
EV-to-FCF

Competitive Comparison of Kimia Biosciences's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kimia Biosciences's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's EV-to-FCF falls into.



Kimia Biosciences EV-to-FCF Calculation

Kimia Biosciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2302.711/
=


Kimia Biosciences  (BOM:530313) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Kimia Biosciences's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=48.67/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Kimia Biosciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines